Literature DB >> 24197700

Associations between TNF-α -308 A/G and lymphotoxin-α +252 A/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis.

Gwan Gyu Song1, Jae-Hoon Kim, Young Ho Lee.   

Abstract

Several studies have examined the effects of the tumor necrosis factor-α (TNF-α) -308 A/G and lymphotoxin-α (LT-α) +252 A/G polymorphisms on susceptibility to sarcoidosis, showing mixed results. The purpose of this study was to examine whether the TNF-α -308 A/G and LT-α +252 A/G polymorphisms confer susceptibility to sarcoidosis. We did a literature search from MEDLINE and EMBASE indices, and conducted a meta-analysis examining the association between TNF-α -308 A/G and LT-α +252 A/G polymorphisms and sarcoidosis. A total of 13 separate comparisons including 1,396 patients with sarcoidosis and 2,344 controls were considered in our meta-analysis. The meta-analysis revealed a significant association between the TNF-α -308 A allele and sarcoidosis (odds ratio [OR] = 1.480, 95 % confidence interval [CI] 1.057-2.073, p = 0.002). Stratification by ethnicity indicated an association between the TNF-α -308 A allele polymorphism and sarcoidosis in Europeans (OR = 1.445, 95 % CI = 1.010-2.065, p = 0.044), but not Asians (OR = 4.693, 95 % CI = 0.548-40.29, p = 0.158). The results also showed a significant association between the LT-α +252 G allele and sarcoidosis (OR = 1.266, 95 % CI = 1.048-1.528, p = 0.014). Stratification by ethnicity indicated an association between the LT-α +252 G allele and sarcoidosis in Europeans (OR = 1.307, 95 % CI = 1.045-1.635, p = 0.019), but not in Asians (OR = 1.169, 95 % CI = 0.824-1.660, p = 0.381). Our meta-analysis demonstrates that the TNF-α -308 A/G and LT-α +252 A/G polymorphisms are associated with susceptibility to sarcoidosis in an European population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24197700     DOI: 10.1007/s11033-013-2859-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

Review 1.  Polymorphism of the human TNF-alpha promoter--random variation or functional diversity?

Authors:  R D Allen
Journal:  Mol Immunol       Date:  1999 Oct-Nov       Impact factor: 4.407

2.  TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis.

Authors:  Janardan P Pandey; Margaret Frederick
Journal:  Hum Immunol       Date:  2002-06       Impact factor: 2.850

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis.

Authors:  Igor Medica; Andrej Kastrin; Ales Maver; Borut Peterlin
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

Review 5.  Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower; Roland M du Bois
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

6.  Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.

Authors:  S Labunski; G Posern; S Ludwig; G Kundt; E B Bröcker; M Kunz
Journal:  Acta Derm Venereol       Date:  2001 Jan-Feb       Impact factor: 4.437

7.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

8.  TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis.

Authors:  R Kieszko; P Krawczyk; S Chocholska; A Dmoszyńska; J Milanowski
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2010-07       Impact factor: 0.670

9.  TNF alpha mRNA, but not IL-1 beta, is differentially expressed in lung macrophages of patients with active pulmonary sarcoidosis.

Authors:  H Kaneshima; S Nagai; T Shimoji; T Tsutsumi; T Mikuniya; N Satake; T Izumi
Journal:  Sarcoidosis       Date:  1994-03

10.  Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.

Authors:  R P Baughman; S A Strohofer; J Buchsbaum; E E Lower
Journal:  J Lab Clin Med       Date:  1990-01
View more
  5 in total

Review 1.  Distinguishing Blau Syndrome from Systemic Sarcoidosis.

Authors:  Katherine P Kaufman; Mara L Becker
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

2.  The Immunogenetics of Granulomatous Diseases.

Authors:  Gizem Filazi Kök; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Interleukin-12 family cytokines and sarcoidosis.

Authors:  Sabine Ringkowski; Paul S Thomas; Cristan Herbert
Journal:  Front Pharmacol       Date:  2014-10-27       Impact factor: 5.810

Review 4.  Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.

Authors:  Pleiades T Inaoka; Masato Shono; Mishio Kamada; J Luis Espinoza
Journal:  J Biomed Sci       Date:  2019-06-11       Impact factor: 8.410

Review 5.  Offense and Defense in Granulomatous Inflammation Disease.

Authors:  Xinwen Wang; Yuan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-29       Impact factor: 6.073

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.